Fusion Acquisition Corp. II
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FSNB research report →
Price Chart
About the company
Fusion Acquisition Corp. II, a special purpose acquisition company (SPAC), was established in 2021 and maintains its headquarters in New York, New York.
- CEO
- John James
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on FSNB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $10.75
- 52W Low
- $9.52
- 50D MA
- $10.46
- 200D MA
- $10.29
- Beta
- 0.01
- RSI (14)
- 56
- Avg Volume
- 35.50K
No earnings-call transcripts are available for FSNB yet.
- Free Float
- 368.2%
- Shares Outstanding
- 16.98M
- Float Shares
- 62.50M
of shares held by institutions
21 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 250.00K | 0 |
| Omni Partners Us LLC | 34.83K | ▼ 13.56K |
| Seaport Global Asset Management LLC | 5.17K | ▲ 5.17K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 1, 23 | COWEN INC. | other | 138,648 |
| Aug 29, 23 | Fusion Sponsor II LLC | other | 12,500,000 |
| Apr 21, 23 | COWEN INC. | sell | 10,100 |
| Apr 21, 23 | COWEN INC. | sell | 4,900 |
| Apr 21, 23 | COWEN INC. | sell | 1,393 |
| Apr 19, 23 | COWEN INC. | buy | 36,400 |
| Apr 19, 23 | COWEN INC. | other | 0 |
| Apr 19, 23 | COWEN INC. | other | 0 |
| Jan 12, 22 | Thoresen Erik | other | 82,400 |
| Mar 2, 21 | Fusion Sponsor II LLC | other | 6,250 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FSNB coverage
Recent articles, reports, and earnings notes.
No research on FSNB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FSNB report →